Clinical Trial

Psilocybin for Hospitalized Patients with Treatment-resistant Depression

Study acronym: PSIHOS-D
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2024 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to determine the safety and feasibility of performing psilocybin-assisted psychotherapy in patients hospitalized for treatment-resistant depression.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-19; most recent amendment 2024-09-05.
Status change: Not Yet Recruiting → Recruiting 2024-04-24
Trial Details
NCT Number NCT06378229
Lead Sponsor University Hospital, Ghent
Collaborators: Filament Health Corp.
Conditions Treatment Resistant Depression
Enrollment 100 participants
Start Date 2024-05-21
Primary Completion 2026-03 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-09-19